RecruitingNCT07130981
Body Composition and Psychosocial Factors in ICI-Treated Cancer Patients
Evaluation of Body Composition, Psychosocial Factors, and Drug-Related Problems in Relation to Clinical Progression in Cancer Patients Receiving Immune Checkpoint Inhibitors
Sponsor
Hacettepe University
Enrollment
200 participants
Start Date
Sep 1, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
Evaluation of the effects of body composition, psychosocial factors, and drug-related problems on clinical progression (such as toxicity, treatment response, and quality of life) in cancer patients treated with immune checkpoint inhibitors
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Aged 18 years or older
- Having undergone a CT scan (at the L3 level) prior to treatment
- No severe mental disorder and able to communicate effectively
- Provided written informed consent
Exclusion Criteria2
- Did not provide written informed consent
- Patients deemed unsuitable by the physician
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07130981
Related Trials
EXOME Analysis Position in the Strategy of Genetic Predisposition Factors Identification in Early-onset Cancer
NCT041414626 locations
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
NCT0683556910 locations
Randomized Controlled Trial of Remote Symptoms Monitoring With Resilience PRO Compared to Care As Usual Only
NCT0686770536 locations
Virtual Reality Intervention to Improve Psychological Symptom Burden for Cancer Patients Undergoing Treatment
NCT072214091 location
The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials
NCT067566071 location